- Home
- INTS vs FEBO Comparison
INTS vs FEBO Comparison
Compare INTS & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- FEBO
- Stock Information
- Founded
- INTS 2012
- FEBO 1993
- Country
- INTS United States
- FEBO Hong Kong
- Employees
- INTS N/A
- FEBO N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- FEBO
- Sector
- INTS Health Care
- FEBO
- Exchange
- INTS Nasdaq
- FEBO Nasdaq
- Market Cap
- INTS 8.4M
- FEBO 8.0M
- IPO Year
- INTS 2023
- FEBO 2023
- Fundamental
- Price
- INTS $0.30
- FEBO $0.66
- Analyst Decision
- INTS Strong Buy
- FEBO
- Analyst Count
- INTS 4
- FEBO 0
- Target Price
- INTS $4.50
- FEBO N/A
- AVG Volume (30 Days)
- INTS 5.8M
- FEBO 21.2K
- Earning Date
- INTS 08-07-2025
- FEBO 09-02-2025
- Dividend Yield
- INTS N/A
- FEBO N/A
- EPS Growth
- INTS N/A
- FEBO N/A
- EPS
- INTS N/A
- FEBO N/A
- Revenue
- INTS N/A
- FEBO $17,110,653.00
- Revenue This Year
- INTS N/A
- FEBO N/A
- Revenue Next Year
- INTS N/A
- FEBO N/A
- P/E Ratio
- INTS N/A
- FEBO N/A
- Revenue Growth
- INTS N/A
- FEBO 11.58
- 52 Week Low
- INTS $0.19
- FEBO $0.61
- 52 Week High
- INTS $4.35
- FEBO $8.50
- Technical
- Relative Strength Index (RSI)
- INTS 49.95
- FEBO 26.66
- Support Level
- INTS $0.28
- FEBO $0.61
- Resistance Level
- INTS $0.32
- FEBO $0.76
- Average True Range (ATR)
- INTS 0.03
- FEBO 0.06
- MACD
- INTS 0.01
- FEBO -0.00
- Stochastic Oscillator
- INTS 78.80
- FEBO 22.22
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.